How to Verify Retatrutide Purity

The Reality of the NZ Market

The current standard in New Zealand is low.

Most — if not all — suppliers fall into one of these categories:

• Claim high purity with zero proof
• Hide COAs completely
• Show generic or reused lab reports
• Provide documents with missing or redacted data

On the surface, everything looks legit.

But when you actually look closer, there is nothing backing it.

That is not a coincidence — it is the standard.

If you are researching active NZ suppliers, pair this with the Where To Buy Retatrutide NZ guide.

Why “99% Purity”
Means Nothing

Anyone can type “99% purity” on a website.

There is no requirement to prove it.

And in most cases, they do not.

So when you see:

• “≥99% purity”
• “lab tested”
• “pharmaceutical grade” — a phrase with no regulatory definition in New Zealand’s research context. It is marketing terminology, not a quality standard.

With no actual report attached, you are looking at marketing, not data.

If you want the broader NZ context around sourcing and market standards, read our retatrutide New Zealand guide.

COAs: What They’re
Supposed to Be

A real Certificate of Analysis should show:

• Mass spec confirmation — the most critical test for peptides, because it verifies molecular identity, not just purity. HPLC alone can miss structural issues entirely.
• Exact purity, not just a claim
• Chromatogram data, meaning the actual test output
• Batch or lot number
• The lab that performed the test

That is what verification looks like.

The broader buyer-side sourcing context is covered in the verified retatrutide NZ sourcing guide.

Anything less is incomplete.

This is also why pages like Is My Retatrutide Fake? matter. Most people are checking labels and supplier claims, but not the actual evidence chain behind the vial.

What a COA Can
And Cannot Prove

A COA is useful, but it is not magic. A strong report can support identity and purity for a tested sample. It does not automatically prove every vial in circulation is sterile, correctly filled, stored properly, or from the same batch.

That is why the strongest standard is not just “has a COA.” It is public, complete, independently verifiable, batch-matched evidence from a named third-party lab.

Step-by-Step Retatrutide
Purity Check

Use this sequence before trusting any purity claim.

• Find the batch number: the vial, product page and COA should point to the same batch or lot.
• Confirm the lab identity: the report should clearly name the third-party laboratory.
• Check HPLC data: look for actual chromatogram output, not only a purity percentage.
• Check mass spec: the report should confirm molecular identity, not just purity.
• Verify externally: use QR codes, report IDs or lab lookup pages where available.
• Reject cropped proof: screenshots, blurred PDFs and missing pages are not proper verification.

The Problem: Fake and
Misleading COAs

This is where it gets worse.

Some suppliers do not just avoid COAs — they fake them.

Common tactics include:

• Using the same COA for multiple batches
• Editing PDFs or removing key sections
• Showing a purity percentage with no raw data
• Hiding lab identity

To the average buyer, it looks legitimate.

But it is not verifiable.

If a COA cannot be independently verified, it should be treated as fake.

Internal Testing =
No Accountability

A lot of suppliers rely on “manufacturer testing”.

That means:

• The same entity producing the product is “testing” it
• There is no independent verification
• There is no accountability if results are wrong

Even if the data is real, you have no way to confirm it.

Which makes it useless for verification.

For a practical breakdown of how questionable products circulate locally, read Is My Retatrutide Fake?.

What Real Verification
Looks Like

There is only one standard that actually matters:

• Independent third-party testing
• Full, unedited reports
• Recognised lab
• Batch-level matching

Labs like Janoshik are often referenced because:

• They provide full chromatograms
• Reports include mass spec confirmation alongside HPLC — verifying both purity and molecular identity
• Reports are traceable
• Data is not controlled by the supplier

That is the difference between a claim and proof.

For a more practical buyer-side check, pair this with our fake retatrutide guide.

QR Codes, Verification IDs
And Real COA Validation

One of the easiest ways to identify a fake or misleading COA is to check whether the report can actually be verified outside the supplier’s website.

Real third-party testing labs often include:

• QR codes
• Verification IDs
• Report lookup systems
• External validation pages

Labs like Janoshik are commonly referenced because buyers can independently verify reports through the laboratory itself rather than relying only on screenshots supplied by the seller.

This matters because edited PDFs and cropped screenshots are extremely common in low-verification peptide markets.

A real verification system allows the buyer to confirm the report exists independently of the supplier. That is a completely different standard from simply uploading a PDF image to a website.

For broader sourcing context, read the Where To Buy Retatrutide NZ guide and the fake retatrutide verification guide.

The Batch Trick
Most People Miss

Even if a COA looks real, there is one question that matters:

Does it match your vial?

Because here is what happens:

• A supplier gets one clean COA
• Then uses it across all future stock

Completely different batch. Same document.

Unless the batch number matches exactly, it means nothing.

This is the simple rule most buyers miss, and it is one of the easiest ways low-standard product keeps moving.

The Simple Rule

If a supplier does not publicly list clear, verifiable COAs on their website, do not trust the product.

Not “ask them for it later”.

Not “they said they can provide it”.

If it is not visible upfront, it is usually because it does not exist.

Medsafe Context
For Purity Claims

Medsafe has warned about unapproved peptide products imported and supplied in New Zealand. The issue is not only whether a product has a good-looking purity claim; the wider risk is that unapproved products have not gone through medicine-level quality, safety and efficacy assessment.

That makes COA verification useful as a risk filter, but not a substitute for regulated medicine supply. A clean-looking COA does not turn an unapproved investigational compound into an approved consumer medicine.

For the full regulatory overview, read the Retatrutide NZ 2026 status guide and the legal status guide.

Why This Matters
More in NZ

New Zealand is a smaller market.

That means:

• Less competition on quality
• More reliance on imported supply chains
• Easier for low-standard products to circulate

Which is why verification matters more here than almost anywhere else.

Right now, the baseline standard is low.

And most suppliers are operating within it.

That is also why independent verification and sourcing transparency matter so much in the NZ retatrutide research market.

What the Standard
Actually Requires

Demand for retatrutide has increased significantly off the back of the TRIUMPH clinical programme. More buyers, more suppliers, more product moving through informal channels — and no corresponding lift in verification standards.

That gap is exactly where under-dosed and misrepresented product circulates.

The expectation should be simple:

• Public COAs — listed on the website, not available on request
• Third-party testing — not manufacturer self-certification
• Full transparency — batch numbers, lab identity, unedited reports

Anything below that should be treated as unverified.

Final Takeaway

This comes down to one thing:

Proof vs claims.

Right now, most suppliers in New Zealand rely on claims.

No data. No verification. No accountability.

Once you understand how COAs work, it becomes very hard to ignore.

And very easy to spot who actually meets a real standard — and who does not.

Common Questions